HARLAN S ROBINS Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for HARLAN S ROBINS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of HARLAN S ROBINS. HARLAN S ROBINS is Chief Scientific Officer in Adaptive Biotechnologies Corp ($ADPT).
Latest Insider Trading Transactions of HARLAN S ROBINS
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 07 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 3,895 | 24,616 | 128,535 | |
| May 07 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 3,895 | 24,616 | 132,430 | |
| May 07 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 36.38 | 847 | 30,814 | 69,360 | 70.2 K to 69.4 K (-1.21 %) |
| May 07 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 35.51 | 3,048 | 108,234 | 70,207 | 73.3 K to 70.2 K (-4.16 %) |
| May 07 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 3,895 | 24,616 | 73,255 | 69.4 K to 73.3 K (+5.62 %) |
| May 07 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 35.43 | 3,195 | 113,199 | 69,360 | 72.6 K to 69.4 K (-4.40 %) |
| May 07 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 3,895 | 24,616 | 73,255 | 69.4 K to 73.3 K (+5.62 %) |
| May 06 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 3,895 | 24,616 | 136,325 | |
| May 06 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 36.80 | 700 | 25,760 | 69,360 | 70.1 K to 69.4 K (-1.00 %) |
| May 06 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 35.99 | 3,195 | 114,988 | 70,060 | 73.3 K to 70.1 K (-4.36 %) |
| May 06 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 3,895 | 24,616 | 73,255 | 69.4 K to 73.3 K (+5.62 %) |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 7,790 | 49,233 | 140,220 | |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 7,790 | 49,233 | 140,220 | |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 7,790 | 49,233 | 148,010 | |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 7,790 | 49,233 | 148,010 | |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 11,685 | 73,849 | 155,800 | |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 11,685 | 73,849 | 155,800 | |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 43.59 | 3,510 | 153,001 | 69,360 | 72.9 K to 69.4 K (-4.82 %) |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 43.59 | 3,510 | 153,001 | 69,360 | 72.9 K to 69.4 K (-4.82 %) |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 42.85 | 4,280 | 183,398 | 72,870 | 77.2 K to 72.9 K (-5.55 %) |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 42.85 | 4,280 | 183,398 | 72,870 | 77.2 K to 72.9 K (-5.55 %) |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 7,790 | 49,233 | 77,150 | 69.4 K to 77.2 K (+11.23 %) |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 7,790 | 49,233 | 77,150 | 69.4 K to 77.2 K (+11.23 %) |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 41.79 | 5,200 | 217,308 | 69,360 | 74.6 K to 69.4 K (-6.97 %) |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 41.79 | 5,200 | 217,308 | 69,360 | 74.6 K to 69.4 K (-6.97 %) |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 41.17 | 2,090 | 86,045 | 74,560 | 76.7 K to 74.6 K (-2.73 %) |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 41.17 | 2,090 | 86,045 | 74,560 | 76.7 K to 74.6 K (-2.73 %) |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 39.85 | 500 | 19,925 | 76,650 | 77.2 K to 76.7 K (-0.65 %) |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 39.85 | 500 | 19,925 | 76,650 | 77.2 K to 76.7 K (-0.65 %) |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 7,790 | 49,233 | 77,150 | 69.4 K to 77.2 K (+11.23 %) |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 7,790 | 49,233 | 77,150 | 69.4 K to 77.2 K (+11.23 %) |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 41.35 | 3,000 | 124,050 | 69,360 | 72.4 K to 69.4 K (-4.15 %) |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 41.35 | 3,000 | 124,050 | 69,360 | 72.4 K to 69.4 K (-4.15 %) |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 40.24 | 8,685 | 349,484 | 72,360 | 81 K to 72.4 K (-10.72 %) |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 40.24 | 8,685 | 349,484 | 72,360 | 81 K to 72.4 K (-10.72 %) |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 11,685 | 73,849 | 81,045 | 69.4 K to 81 K (+16.85 %) |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 11,685 | 73,849 | 81,045 | 69.4 K to 81 K (+16.85 %) |
| Mar 25 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 5,290 | 33,433 | 167,485 | |
| Mar 25 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 6,395 | 40,416 | 172,775 | |
| Mar 25 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 7,790 | 49,233 | 179,170 | |
| Mar 25 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 38.72 | 1,481 | 57,344 | 69,360 | 70.8 K to 69.4 K (-2.09 %) |
| Mar 25 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 38.13 | 3,809 | 145,237 | 70,841 | 74.7 K to 70.8 K (-5.10 %) |
| Mar 25 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 5,290 | 33,433 | 74,650 | 69.4 K to 74.7 K (+7.63 %) |
| Mar 25 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 41.76 | 400 | 16,704 | 69,360 | 69.8 K to 69.4 K (-0.57 %) |
| Mar 25 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 40.33 | 4,175 | 168,378 | 69,760 | 73.9 K to 69.8 K (-5.65 %) |
| Mar 25 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 39.43 | 1,820 | 71,763 | 73,935 | 75.8 K to 73.9 K (-2.40 %) |
| Mar 25 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 6,395 | 40,416 | 75,755 | 69.4 K to 75.8 K (+9.22 %) |
| Mar 25 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 41.93 | 7,790 | 326,635 | 69,360 | 77.2 K to 69.4 K (-10.10 %) |
| Mar 25 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 7,790 | 49,233 | 77,150 | 69.4 K to 77.2 K (+11.23 %) |
| Mar 08 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | A | 43.68 | 171,703 | 7,499,987 | 171,703 | |
| Mar 08 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Grant | A | 0.00 | 68,681 | 0 | 69,360 | 679 to 69.4 K (+10,115.02 %) |
| Feb 05 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 7,790 | 49,233 | 186,960 | |
| Feb 05 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 60.34 | 860 | 51,892 | 679 | 1.5 K to 679 (-55.88 %) |
| Feb 05 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 59.49 | 6,930 | 412,266 | 1,539 | 8.5 K to 1.5 K (-81.83 %) |
| Feb 05 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 7,790 | 49,233 | 8,469 | 679 to 8.5 K (+1,147.28 %) |
| Feb 03 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 7,790 | 49,233 | 194,750 | |
| Feb 03 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 7,790 | 49,233 | 202,540 | |
| Feb 03 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 60.57 | 2,379 | 144,096 | 679 | 3.1 K to 679 (-77.80 %) |
| Feb 03 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 59.80 | 2,501 | 149,560 | 3,058 | 5.6 K to 3.1 K (-44.99 %) |
| Feb 03 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 58.76 | 2,910 | 170,992 | 5,559 | 8.5 K to 5.6 K (-34.36 %) |
| Feb 03 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 7,790 | 49,233 | 8,469 | 679 to 8.5 K (+1,147.28 %) |
| Feb 03 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 56.18 | 3,590 | 201,686 | 679 | 4.3 K to 679 (-84.09 %) |
| Feb 03 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 55.54 | 4,200 | 233,268 | 4,269 | 8.5 K to 4.3 K (-49.59 %) |
| Feb 03 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 7,790 | 49,233 | 8,469 | 679 to 8.5 K (+1,147.28 %) |
| Jan 25 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 23,370 | 147,698 | 210,330 | |
| Jan 25 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 67.59 | 2,100 | 141,939 | 679 | 2.8 K to 679 (-75.57 %) |
| Jan 25 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 66.90 | 17,329 | 1,159,310 | 2,779 | 20.1 K to 2.8 K (-86.18 %) |
| Jan 25 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 66.06 | 3,941 | 260,342 | 20,108 | 24 K to 20.1 K (-16.39 %) |
| Jan 25 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 23,370 | 147,698 | 24,049 | 679 to 24 K (+3,441.83 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 50,000 | 316,000 | 133,700 | |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 50,000 | 316,000 | 183,700 | |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 68.20 | 4,661 | 317,880 | 679 | 5.3 K to 679 (-87.28 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 67.39 | 24,945 | 1,681,044 | 5,340 | 30.3 K to 5.3 K (-82.37 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 66.84 | 20,394 | 1,363,135 | 30,285 | 50.7 K to 30.3 K (-40.24 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 50,000 | 316,000 | 50,679 | 679 to 50.7 K (+7,363.77 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 70.75 | 2,100 | 148,575 | 679 | 2.8 K to 679 (-75.57 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 69.97 | 8,052 | 563,398 | 2,779 | 10.8 K to 2.8 K (-74.34 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 69.26 | 5,701 | 394,851 | 10,831 | 16.5 K to 10.8 K (-34.48 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 67.74 | 3,001 | 203,288 | 16,532 | 19.5 K to 16.5 K (-15.36 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 67.02 | 31,146 | 2,087,405 | 19,533 | 50.7 K to 19.5 K (-61.46 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 50,000 | 316,000 | 50,679 | 679 to 50.7 K (+7,363.77 %) |
| Nov 06 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 11,100 | 70,152 | 233,700 | |
| Nov 06 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 11,100 | 70,152 | 244,800 | |
| Nov 06 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 11,100 | 70,152 | 255,900 | |
| Nov 06 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 52.50 | 900 | 47,250 | 679 | 1.6 K to 679 (-57.00 %) |
| Nov 06 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 51.57 | 8,700 | 448,659 | 1,579 | 10.3 K to 1.6 K (-84.64 %) |
| Nov 06 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 50.48 | 1,500 | 75,720 | 10,279 | 11.8 K to 10.3 K (-12.73 %) |
| Nov 06 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 11,100 | 70,152 | 11,779 | 679 to 11.8 K (+1,634.76 %) |
| Nov 06 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 50.88 | 3,846 | 195,684 | 679 | 4.5 K to 679 (-84.99 %) |
| Nov 06 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 50.00 | 7,254 | 362,700 | 4,525 | 11.8 K to 4.5 K (-61.58 %) |
| Nov 06 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 11,100 | 70,152 | 11,779 | 679 to 11.8 K (+1,634.76 %) |
| Nov 06 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 50.98 | 1,300 | 66,274 | 679 | 2 K to 679 (-65.69 %) |
| Nov 06 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 50.20 | 9,800 | 491,960 | 1,979 | 11.8 K to 2 K (-83.20 %) |
| Nov 06 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 11,100 | 70,152 | 11,779 | 679 to 11.8 K (+1,634.76 %) |
| Oct 20 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 11,100 | 70,152 | 267,000 | |
| Oct 20 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 51.79 | 11,100 | 574,869 | 679 | 11.8 K to 679 (-94.24 %) |
| Oct 20 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 11,100 | 70,152 | 11,779 | 679 to 11.8 K (+1,634.76 %) |
| Oct 16 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 11,100 | 70,152 | 278,100 | |
| Oct 16 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 11,100 | 70,152 | 289,200 | |
| Oct 16 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 51.55 | 11,100 | 572,205 | 679 | 11.8 K to 679 (-94.24 %) |
| Oct 16 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 11,100 | 70,152 | 11,779 | 679 to 11.8 K (+1,634.76 %) |
| Oct 16 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 52.84 | 3,480 | 183,883 | 679 | 4.2 K to 679 (-83.67 %) |
| Oct 16 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 51.87 | 7,620 | 395,249 | 4,159 | 11.8 K to 4.2 K (-64.69 %) |
| Oct 16 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 11,100 | 70,152 | 11,779 | 679 to 11.8 K (+1,634.76 %) |
| Sep 24 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 11,100 | 70,152 | 300,300 | |
| Sep 24 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 11,100 | 70,152 | 311,400 | |
| Sep 24 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 11,100 | 70,152 | 322,500 | |
| Sep 24 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 47.98 | 3,900 | 187,122 | 679 | 4.6 K to 679 (-85.17 %) |
| Sep 24 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 47.28 | 3,560 | 168,317 | 4,579 | 8.1 K to 4.6 K (-43.74 %) |
| Sep 24 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 46.00 | 3,640 | 167,440 | 8,139 | 11.8 K to 8.1 K (-30.90 %) |
| Sep 24 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 11,100 | 70,152 | 11,779 | 679 to 11.8 K (+1,634.76 %) |
| Sep 24 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 48.16 | 11,100 | 534,576 | 679 | 11.8 K to 679 (-94.24 %) |
| Sep 24 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 11,100 | 70,152 | 11,779 | 679 to 11.8 K (+1,634.76 %) |
| Sep 24 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 47.95 | 4,100 | 196,595 | 679 | 4.8 K to 679 (-85.79 %) |
| Sep 24 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 47.34 | 7,000 | 331,380 | 4,779 | 11.8 K to 4.8 K (-59.43 %) |
| Sep 24 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 11,100 | 70,152 | 11,779 | 679 to 11.8 K (+1,634.76 %) |
| Aug 24 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 11,100 | 70,152 | 333,600 | |
| Aug 24 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 11,100 | 70,152 | 344,700 | |
| Aug 24 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 11,100 | 70,152 | 355,800 | |
| Aug 24 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 43.14 | 10,750 | 463,755 | 679 | 11.4 K to 679 (-94.06 %) |
| Aug 24 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 42.58 | 350 | 14,903 | 11,429 | 11.8 K to 11.4 K (-2.97 %) |
| Aug 24 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 11,100 | 70,152 | 11,779 | 679 to 11.8 K (+1,634.76 %) |
| Aug 24 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 43.35 | 4,630 | 200,711 | 679 | 5.3 K to 679 (-87.21 %) |
| Aug 24 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 42.63 | 6,470 | 275,816 | 5,309 | 11.8 K to 5.3 K (-54.93 %) |
| Aug 24 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 11,100 | 70,152 | 11,779 | 679 to 11.8 K (+1,634.76 %) |
| Aug 24 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 42.91 | 6,900 | 296,079 | 679 | 7.6 K to 679 (-91.04 %) |
| Aug 24 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 41.77 | 4,200 | 175,434 | 7,579 | 11.8 K to 7.6 K (-35.66 %) |
| Aug 24 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 11,100 | 70,152 | 11,779 | 679 to 11.8 K (+1,634.76 %) |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 11,100 | 70,152 | 366,900 | |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 11,100 | 70,152 | 366,900 | |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 22,200 | 140,304 | 378,000 | |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 22,200 | 140,304 | 378,000 | |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 40.23 | 1,706 | 68,632 | 679 | 2.4 K to 679 (-71.53 %) |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 40.23 | 1,706 | 68,632 | 679 | 2.4 K to 679 (-71.53 %) |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 39.62 | 8,194 | 324,646 | 2,385 | 10.6 K to 2.4 K (-77.46 %) |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 39.62 | 8,194 | 324,646 | 2,385 | 10.6 K to 2.4 K (-77.46 %) |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 38.61 | 1,200 | 46,332 | 10,579 | 11.8 K to 10.6 K (-10.19 %) |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 38.61 | 1,200 | 46,332 | 10,579 | 11.8 K to 10.6 K (-10.19 %) |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 11,100 | 70,152 | 11,779 | 679 to 11.8 K (+1,634.76 %) |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 11,100 | 70,152 | 11,779 | 679 to 11.8 K (+1,634.76 %) |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 39.92 | 7,380 | 294,610 | 679 | 8.1 K to 679 (-91.57 %) |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 39.92 | 7,380 | 294,610 | 679 | 8.1 K to 679 (-91.57 %) |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 39.39 | 14,820 | 583,760 | 8,059 | 22.9 K to 8.1 K (-64.78 %) |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 39.39 | 14,820 | 583,760 | 8,059 | 22.9 K to 8.1 K (-64.78 %) |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 22,200 | 140,304 | 22,879 | 679 to 22.9 K (+3,269.51 %) |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 22,200 | 140,304 | 22,879 | 679 to 22.9 K (+3,269.51 %) |
| Jun 25 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 11,100 | 70,152 | 400,200 | |
| Jun 25 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 11,100 | 70,152 | 411,300 | |
| Jun 25 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 11,100 | 70,152 | 422,400 | |
| Jun 25 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 47.25 | 3,743 | 176,857 | 679 | 4.4 K to 679 (-84.64 %) |